Delivery Order SPE2DB22D3011-SPE2DB25FQ2SP
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,937.76 to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count supply) with a firm fixed price structure. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside procurement. Performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's $999.9...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,768.44, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded delivery order was issued on August 19, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count) valued at $1,842.99 under a firm fixed price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,536.88 to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) under a firm fixed price contract. The award was made on July 30, 2025, with a completion date of July 31, 2025, and performance will be executed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting the vendor's established capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,219.60 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor headquartered in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of XCOPRI 50 MG tablets (30-count packages) valued at $7,622.85. This firm fixed-price delivery order represents a non-competitive award and carries an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,178.96 delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count units) under a firm fixed price contract with a completion date of July 22, 2025. This non-set-aside award was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's larger federal pharmaceutical supply arrangement with DLA....
- The Defense Logistics Agency awarded a $7,634.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) with an ultimate completion date of September 9, 2025. This non-set-aside contract represents a competitively awarded transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,883.74 to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count package) on September 12, 2025, with completion targeted for September 15, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,964.26 to AmerisourceBergen Drug Corp for 30 tablets of XCOPRI 100 mg on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, competitively awarded contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. The order represents a relatively...